NLRC3 enhances antitumor immunity by specifically negatively regulating M-MDSCs in a STING-dependent manner.

NLRC3 enhances antitumor immunity by inhibiting M-MDSC infiltration and function through a STING-dependent pathway, reducing tumor growth.

• Why it matters: Understanding how immune suppressor cells like M-MDSCs are regulated is crucial for developing effective cancer immunotherapies, as these cells hinder immune responses against tumors.
• What they did: The study used overexpression of NLRC3 and STING pathway activation with c-GAMP to investigate their effects on tumor growth and M-MDSC activity, focusing on molecular mechanisms involving PD-L1 and CCR2.
• The result: Findings show NLRC3 suppresses M-MDSC infiltration and immunosuppressive functions, and combined NLRC3 overexpression with STING activation significantly inhibits tumor progression, informing potential therapeutic strategies.